It is essential to continue collecting blood and blood components to support healthcare delivery. This guidance is for administration, staff, and volunteers at blood and plasma collection facilities.
Public health guidance may shift. Be aware of updates to local and state public health recommendations and if COVID-19 becomes more widespread and/or more clinically severe.
CDC is working with FDA, state and local health departments, and other HHS agencies to monitor COVID-19 and its potential impact on blood availability and blood safety.
CDC and other HHS agencies are also continuing to work with the AABB Interorganizational Disaster Task Force to enhance preparednesspdf iconexternal icon.
Read more on cdc.gov